Investor · Boston, MA
Andrew Levin
Open Andrew in the network graph →Filings
68
SEC Form D
Connections
353
co-filers
Capital
$359.7M
across filings
Active
Aug 2012
to Mar 2026
Most-connected co-filers (353)
Valerie Morisset · Boston, MA9 sharedSimon Tate · Cambridge, United Kingdom9 sharedJoshua Resnick · Los Angeles, CA9 sharedJoseph Hargrave · San Francisco, CA6 sharedAoife Brennan · Wilmington, DE6 sharedTeresa Y. Bernstein · WASHINGTON, Washington, D.C.6 sharedPeter B. Finn · Boston, MA5 sharedRobert Poulin · Arlington, VA5 sharedCharles Dunn · ROHNERT PARK, CA5 sharedAdam Rosenberg · Boston, MA5 sharedHans Miller · Arlington, VA5 sharedNikhil Thakur, Md · Andover, MA5 sharedJudith Dunn · Wilmington, DE5 sharedJoe C. Loy · Weatherford, TX4 sharedIain Whyte · Pasadena, CA4 sharedVikram S. Kumar · Cambridge, MA4 sharedMichael Mcadams · Pasadena, CA4 sharedThomas D. Estes · Atlanta, GA4 sharedLiam O. Ratcliffe · New York, NY4 sharedDavid Scadden · Cambridge, MA4 sharedDavid N. Shafer · IRVINE, CA4 sharedRavikiran R. Thummalapenta · Centreville, VA4 sharedJames Schneider · Boston, MA4 sharedGregory M. Gentile · New York, NY4 shared
Recent filings (68)
Slate Medicines, Inc.Mar 2026 · 5 co-filers$130.0MSolstice Oncology, Inc.Mar 2026 · 6 co-filers$298.4MImbria Pharmaceuticals, Inc.Dec 2025 · 19 co-filers$144.2MZETAGEN THERAPEUTICS, INC.Nov 2025 · 17 co-filers$13.0MThyme Care, Inc.Sep 2025 · 35 co-filers$100.0MSuperluminal Medicines, Inc.Aug 2025 · 7 co-filers$5.0MSuperluminal Medicines, Inc.Aug 2025 · 7 co-filers$5.0MPahr Therapeutics, Inc.Jul 2025 · 9 co-filers$14.0MPahr Therapeutics, Inc.Jul 2025 · 9 co-filers$14.0MImbria Pharmaceuticals, Inc.Apr 2025 · 15 co-filers$124.2MPasadena Private Lending Inc.Mar 2025 · 14 co-filersZETAGEN THERAPEUTICS, INC.Jan 2025 · 17 co-filers$6.2MAktis Oncology, Inc.Oct 2024 · 8 co-filers$175.0MSuperluminal Medicines, Inc.Sep 2024 · 9 co-filers$120.0MSuperluminal Medicines, Inc.Sep 2024 · 9 co-filers$120.0MThyme Care, Inc.Jul 2024 · 29 co-filers$54.5MEliem Therapeutics, Inc.Jul 2024 · 23 co-filers$41.9MEliem Therapeutics, Inc.Jul 2024 · 23 co-filers$120.0MEliem Therapeutics, Inc.Jul 2024 · 23 co-filers$41.9MEliem Therapeutics, Inc.Jul 2024 · 23 co-filers$120.0MTrive Capital Fund V LPJun 2024 · 5 co-filersPasadena Private Lending Inc.Apr 2024 · 14 co-filersLion Point International, LtdMar 2024 · 8 co-filersPasadena Private Finance, LLCMar 2024 · 14 co-filersKKR FS Income TrustMar 2024 · 47 co-filers$5.0B
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Andrew in the interactive graph →